MSManon Suerink

Manon Suerink

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manon Suerink has a total of 346 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Increasing clinical utility of prenatal exome sequencing: the potential power of phenotype-driven Artificial Intelligence analysis

    by Manon Suerink, Mariette Hoffer, Alexander Dingemans, Ilse Feenstra, Malou Heijligers, Dineke Westra, Helger Yntema, Galuh Astuti, Mariet Elting, Marielle van Gijn, et al.

    Prenatal exome sequencing (pES) is challenging due to rapid turnaround requirements and limited phenotype information. Analysis strategies span gene panels through exome-wide review, with Artificial Intelligence (AI) as optional support. We evaluated how these approaches impact clinical utility of pES. We prospectively included 233 parental-foetal trios. Analysis results from virtual gene panels (Foetal Anomalies and DDG2P) and an AI-driven variant interpretation platform, were compared with clinical diagnostic work-up, assessing causative variants, phenotype-relevant variants of uncertain significance (VUS) and incidental findings (IF). Diagnostic yield of AI and both gene panels was 14.2% (N = 33 cases). AI and gene panel analysis both missed one diagnosis that was made in clinical diagnostic work-up. AI ranked all causative variants in the top five, except for a low-level mosaic variant below the review threshold. Rates of VUS and IF did not differ significantly across approaches. The number of prioritized variants did not correlate with HPO-term specificity or number, while newer AI versions prioritized significantly fewer variants. Alternative analyses strategies had similar diagnostic yield compared to routine diagnostic work-up. Phenotype-driven AI reliably prioritized causal variants and could help streamline variant interpretation. These outcomes show the potential of phenotype-driven AI to increase clinical utility.

    • 1 April 2026
      • Vol. 35  (2) , e70187
    Open Access

    Experiences of Dutch parents undergoing prenatal genomic testing for fetal structural anomalies: A prospective qualitative analysis.

    by Maayke A de Koning, Sarah Long, Holly E Evans, Lauren Kelada, Gijs W E Santen, Tony Roscioli, Manon Suerink

    Prenatal Exome Sequencing (pES) increases the diagnostic rate for genetic disorders in pregnancies with structural abnormalities and substantially impacts parental decision-making regarding pregnancy continuation or termination. Previous qualitative research on parental experiences of pES has typically been performed several months after results were returned to parents. Moreover, parental experiences of pES might be dependent on cultural aspects and country-specific healthcare systems. This research therefore prospectively explores experiences of families undergoing pES in the Netherlands. Expectant parents undergoing pES because of ultrasound anomalies were invited to participate with two interviews: interview T1 after counseling for genetic testing but prior to return of results and interview T2 six months after return of results. We translated a previously designed Australian interview script, used in similar research, to Dutch, including four open-end and two multiple-choice questions in addition to demographic details. An inductive content analysis approach was used for coding and analysis. Twelve families were interviewed at T1, of which five participants agreed to T2 follow-up interviews. We constructed six content categories of importance: (1) Prenatal feelings of fear, uncertainty, guilt, and anxiety; (2) conflicting feelings in the face of (un)certainty; (3) overall satisfaction with genetic counseling; (4) decision-making influenced by desire for information about their child's quality of life; (5) decision-making influenced by reproductive options and family planning; and (6) importance of empathy, kindness, and clear communication from friends, family, and healthcare professionals. Many content categories show overlap to previous research. However, families in this cohort did not explicitly express negative opinions about waiting on results which is possibly explained by concurrently running multiple genetic testing modalities. Moreover, all participants mentioned positive experiences of the provided healthcare, partly because of swift multidisciplinary collaboration. This study highlights the value of pre-test counseling by clinical geneticists and shows the need for close collaboration between feto-maternal specialists, clinical geneticists, and laboratory specialists.

  • Open Access

    Experiences of Dutch parents undergoing prenatal genomic testing for fetal structural anomalies: A prospective qualitative analysis

    by Maayke A. de Koning, Sarah Long, Holly E. Evans, Lauren Kelada, Gijs W. E. Santen, Tony Roscioli, Manon Suerink

    Prenatal Exome Sequencing (pES) increases the diagnostic rate for genetic disorders in pregnancies with structural abnormalities and substantially impacts parental decision‐making regarding pregnancy continuation or termination. Previous qualitative research on parental experiences of pES has typically been performed several months after results were returned to parents. Moreover, parental experiences of pES might be dependent on cultural aspects and country‐specific healthcare systems. This research therefore prospectively explores experiences of families undergoing pES in the Netherlands. Expectant parents undergoing pES because of ultrasound anomalies were invited to participate with two interviews: interview T1 after counseling for genetic testing but prior to return of results and interview T2 six months after return of results. We translated a previously designed Australian interview script, used in similar research, to Dutch, including four open‐end and two multiple‐choice questions in addition to demographic details. An inductive content analysis approach was used for coding and analysis. Twelve families were interviewed at T1, of which five participants agreed to T2 follow‐up interviews. We constructed six content categories of importance: (1) Prenatal feelings of fear, uncertainty, guilt, and anxiety; (2) conflicting feelings in the face of (un)certainty; (3) overall satisfaction with genetic counseling; (4) decision‐making influenced by desire for information about their child's quality of life; (5) decision‐making influenced by reproductive options and family planning; and (6) importance of empathy, kindness, and clear communication from friends, family, and healthcare professionals. Many content categories show overlap to previous research. However, families in this cohort did not explicitly express negative opinions about waiting on results which is possibly explained by concurrently running multiple genetic testing modalities. Moreover, all participants mentioned positive experiences of the provided healthcare, partly because of swift multidisciplinary collaboration. This study highlights the value of pre‐test counseling by clinical geneticists and shows the need for close collaboration between feto‐maternal specialists, clinical geneticists, and laboratory specialists.

  • Open Access

    “The Way We Do Things is Unsustainable” —Exploring Symptoms of Burnout Among Healthcare Professionals in Prenatal Genomics

    by Maayke de Koning, Sarah Long, Marit de Vries, Holly Evans, Lauren Kelada, Monique Haak, Gemma Fernihough, Gijs Santen, Manon Suerink, Tony Roscioli

    Objectives: This research explored a cross‐country comparison of qualitative and quantitative data assessing the experiences of prenatal genomic healthcare professionals (HCP) in Australia and the Netherlands. Method: The interview script included open‐ended questions on work experience, validated scales on compassion fatigue and stress, and demographic details. Content analysis with an inductive coding approach was used for the coding and analysis of qualitative data. Quantitative data were compared between professions and countries, using a one‐way ANCOVA. Results: Quantitative data were obtained from 93 participants and qualitative data from a subset of 63 participants, recruited from the departments of clinical genetics, maternal‐fetal medicine and genomic laboratories. The following themes were constructed: (1) Advancements in prenatal genomics increase diagnostic rates but cause increased workloads; (2) Benefits and drawbacks of the current healthcare system; (3) The burden of equivocality: high stakes and ambiguous findings; and (4) Multidisciplinary teamwork, support and supervision may improve working conditions. There were no significant differences in compassion fatigue between professions, but Australian HCPs experienced significantly more symptoms of burnout and secondary traumatic stress than Dutch HCPs. Conclusion: Although participants had overall positive views and experiences, with high levels of job satisfaction and low levels of compassion fatigue, additional resources are required to minimize professional burnout while dealing with increasing demands.


  • Open Access

    ERN GENTURIS guideline on counselling on reproductive options for individuals with a cancer predisposition syndrome (including genturis)

    by Said C. Farschtschi, Candy Kumps, Tamara Hussong Milagre, Periklis Makrythanasis, Ariane Van Tongerloo, Ellen Denayer, Mariëtte van Kouwen, Estela Carrasco López, Anna Sophie Berghoff, Salvo Testa, et al.

    Cancer predisposition syndromes (CPSs), including genetic tumour risk syndromes (genturis), are a heterogeneous group of genetic disorders characterised by an increased risk of developing tumours compared to the general population. CPSs raise reproductive issues for affected individuals because of the risk of passing the disease-causing genetic alterations on to offspring. The demand for reproductive counselling is often unmet due to the lack of sufficient healthcare professionals with the specialised knowledge, experience and skill. Based on a comprehensive literature review of 851 publications and expert consensus (multidisciplinary medical experts and patient representatives), the European Reference Network on genetic tumour risk syndromes (ERN GENTURIS) developed a guideline providing 16 recommendations for reproductive counselling in CPSs. The central recommendation is to offer reproductive counselling proactively to all individuals with a CPS and their relevant family members, together with psychological support and in multidisciplinary collaborations. This guideline aims to standardize the offer of reproductive counselling for individuals with a CPS across Europe, empowers healthcare professionals for their specific tasks, and helps patients dealing with their own challenges.


  • Prenatal Variants of Uncertain Significance (VUS): to report or not to report?

    by Maayke A. de Koning, Malgorzata I. Srebniak, Esther J. Oldekamp, Denise Hahn, Karin E. M. Diderich, Hennie T. Bruggenwirth, Gijs W. E. Santen, Mariëtte J. V. Hoffer, Manon Suerink

    Prenatal Exome Sequencing (pES) has a significant diagnostic yield but time pressure and limited phenotypic information make interpretation of Variants of Uncertain Significance (VUS) more challenging than in a postnatal setting. We share our experiences of prenatal reporting of highly suspicious VUS. We retrospectively analyzed pregnancies in which VUS identified by pES were reported to parents during pregnancy in two Dutch academic medical hospitals. During the study period, 31 VUS in 28 genes were reported in 27 pregnancies. Cases were assigned to one of five groups based on consistency of prenatal phenotypes with gene-associated diagnoses. The implications of VUS included clinical evaluation of parental carriers (N = 4), additional screening of proband (N = 2), influencing parental decision-making (N = 11) and/or prompting confirmatory testing (N = 10). Reanalysis with currently available data resulted in reclassification of seven variants, five of which were upgraded to (likely) pathogenic. Although we do not recommend routine disclosure, our data suggest that prenatal reporting of VUS can be valuable in exceptional cases. Stringent selection was applied and only a minority of reported VUS was reclassified as (likely) pathogenic. Therefore, a careful individual assessment of each VUS case remains imperative and multidisciplinary meetings should be an integral part of prenatal VUS management.


  • Open Access

    Prevalence and consequences of APC mosaicism in patients with colorectal adenomas

    by Diantha Terlouw, Manon Suerink, Yentl Buitelaar, Monique E van Leerdam, Frederik J Hes, Demi van Egmond, Dina Ruano, Anja Wagner, Floris H Groenendijk, Isabelle C Meijssen, et al.

    Background and aims: A substantial proportion of patients with adenomatous polyposis have no germline pathogenic variant in APC . The aim of this study was to determine the prevalence of APC mosaicism in these patients with unexplained polyposis and to draft guidelines for APC mosaicism testing and surveillance. Methods: APC mosaicism was analyzed by targeted Next-Generation sequencing in 542 patients with a broad spectrum of polyposis phenotypes. Results: The rate of APC mosaicism was 9.4%. This rate was 14.3% (46/322) in patients who meet the scope of national hereditary polyposis testing guidelines (≥10 adenomas before the age of 60 or with ≥20 adenomas before the age of 70). In patients who do not meet the scope of national guidelines, the detection rate was 2.3% (5/219). In patients with ≥20 adenomas before the age of 60, or ≥30 adenomas before the age of 70 the detection rate was ≥10%. Of 34 mosaic patients who underwent an esophagogastroduodenoscopy, 26% were diagnosed with gastroduodenal polyps. In one patient, the mosaic variant was detected in semen, but none of the children tested in this cohort inherited the mosaic variant. Conclusion: We recommend APC mosaicism testing at least in patients negative for germline pathogenic variants with (1) ≥20 adenomas before the age of 60 or (2) ≥30 adenomas before the age of 70. Regular colonoscopy and at least one gastroduodenoscopy should be offered to APC mosaics, with frequency of follow-up based on findings. Offering germline testing for offspring should be considered.

  • Open Access

    ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management

    by Chrystelle Colas, Léa Guerrini-Rousseau, Manon Suerink, Richard Gallon, Christian P. Kratz, Éloïse Ayuso, Laurence Brugières, Katharina Wimmer, Felipe Andreiuolo, Amedeo A. Azizi, et al.

    Constitutional mismatch repair deficiency (CMMRD), first described 25 years ago, confers an extremely high and lifelong cancer risk, including haematologic, brain, and gastrointestinal tract malignancies, and is associated with several non-neoplastic features. Our understanding of this condition has improved and novel assays to assist CMMRD diagnosis have been developed. Surveillance protocols need adjustment taking into account recent observational prospective studies assessing their effectiveness. Response to immune checkpoint inhibitors and the effectiveness and toxicity of other treatments have been described. An update and merging of the different guidelines on diagnosis and clinical management of CMMRD into one comprehensive guideline was needed. Seventy-two expert members of the European Reference Network GENTURIS and/or the European care for CMMRD consortium and one patient representative developed recommendations for CMMRD diagnosis, genetic counselling, surveillance, quality of life, and clinical management based on a systematic literature search and comprehensive literature review and a modified Delphi process. Recommendations for the diagnosis of CMMRD provide testing criteria, propose strategies for CMMRD testing, and define CMMRD diagnostic criteria. Recommendations for surveillance cover each CMMRD-associated tumour type and contain information on starting age, frequency, and surveillance modality. Recommendations for clinical management cover cancer treatment, management of benign tumours or non-neoplastic features, and chemoprevention. Recommendations also address genetic counselling and quality of life. Based on existing guidelines and currently available data, we present 82 recommendations to improve and standardise the care of CMMRD patients in Europe. These recommendations are not meant to be prescriptive and may be adjusted based on individual decisions.


  • Open Access

    Correction: Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals

    by Dana E. Layo-Carris, Emily E. Lubin, Annabel K. Sangree, Kelly J. Clark, Emily L. Durham, Elizabeth M. Gonzalez, Sarina Smith, Rajesh Angireddy, Xiao Min Wang, Erin Weiss, et al.


  • Open Access

    Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals

    by Dana E. Layo-Carris, Emily E. Lubin, Annabel K. Sangree, Kelly J. Clark, Emily L. Durham, Elizabeth M. Gonzalez, Sarina Smith, Rajesh Angireddy, Xiao Min Wang, Erin Weiss, et al.

    Bryant-Li-Bhoj syndrome (BLBS), which became OMIM-classified in 2022 (OMIM: 619720, 619721), is caused by germline variants in the two genes that encode histone H3.3 (H3-3A/H3F3A and H3-3B/H3F3B) [1–4]. This syndrome is characterized by developmental delay/intellectual disability, craniofacial anomalies, hyper/hypotonia, and abnormal neuroimaging [1, 5]. BLBS was initially categorized as a progressive neurodegenerative syndrome caused by de novo heterozygous variants in either H3-3A or H3-3B [1–4]. Here, we analyze the data of the 58 previously published individuals along 38 unpublished, unrelated individuals. In this larger cohort of 96 people, we identify causative missense, synonymous, and stop-loss variants. We also expand upon the phenotypic characterization by elaborating on the neurodevelopmental component of BLBS. Notably, phenotypic heterogeneity was present even amongst individuals harboring the same variant. To explore the complex phenotypic variation in this expanded cohort, the relationships between syndromic phenotypes with three variables of interest were interrogated: sex, gene containing the causative variant, and variant location in the H3.3 protein. While specific genotype-phenotype correlations have not been conclusively delineated, the results presented here suggest that the location of the variants within the H3.3 protein and the affected gene (H3-3A or H3-3B) contribute more to the severity of distinct phenotypes than sex. Since these variables do not account for all BLBS phenotypic variability, these findings suggest that additional factors may play a role in modifying the phenotypes of affected individuals. Histones are poised at the interface of genetics and epigenetics, highlighting the potential role for gene-environment interactions and the importance of future research.